Wins two federal contracts to supply more than 7.5 mil. doses of its Fluzone influenza vaccine, tetanus and diphtheria toxoids and YF-VAX yellow fever vaccine to the Defense Personnel Support Center and the Centers for Disease Control, vaccine maker announces July 18. The military and their dependents use all three vaccines, while CDC distributes the tetanus and diphtheria toxoids to state and local health departments and Fluzone as part of its Influenza Vaccine Demonstration Project, Connaught said.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth